Search results for "Diabetes"


 
Results 41 - 50 of about 883 for "Diabetes".
Sort by: Relevance | Newest | Oldest

Get comfortable talking about obesity

Kimberly N. Sims, MD, FACP, explains ways to make obesity counseling easier for patients and for their doctors.
https://acpinternist.org/archives/2022/04/get-comfortable-talking-about-obesity.htm
1 Apr 2022

Updated warnings on fluoroquinolones, new diabetes drug

This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://acpinternist.org/archives/2016/10/fda.htm
1 Oct 2016

GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis

Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a new analysis of previous trials found.
https://acpinternist.org/weekly/archives/2014/09/23/2.htm
23 Sep 2014

Reconciling conflicting diabetes guidance

ACP and other professional medical societies disagree on a proper target for the long-term benefits of glucose control.
https://acpinternist.org/archives/2018/06/reconciling-conflicting-diabetes-guidance.htm
1 Jun 2018

Finances can offer clues to cognitive problems

A study found that patients with Alzheimer's disease and related dementias were more likely to miss payments on credit accounts as early as six years before diagnosis and to develop subprime credit scores 2.5 years before diagnosis.
https://acpinternist.org/archives/2022/05/finances-can-offer-clues-to-cognitive-problems.htm
1 May 2022

Meta-analysis compares mortality benefits of heart failure treatment combinations

Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://acpinternist.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021

MKSAP Quiz: Treatment of elevated cholesterol levels

A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://acpinternist.org/weekly/archives/2021/12/14/3.htm
14 Dec 2021

MKSAP Quiz: Follow-up for stable chronic kidney disease

A 57-year-old man is evaluated during follow-up for stable chronic kidney disease diagnosed 1 year ago. He also has type 2 diabetes mellitus, hyperlipidemia, and peripheral artery disease. On physical examination, blood pressure is 128/74 mm Hg, pulse rate is 65/min, and respiration rate is 18/min. Bilateral carotid and lower abdominal quadrant bruits are heard. Peripheral extremity pulses are diminished. The remainder of the examination is normal. After laboratory studies, what is the appropriate management?
https://acpinternist.org/weekly/archives/2021/11/09/3.htm
9 Nov 2021

Nearly 50% of older U.S. adults reported taking aspirin preventively

A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://acpinternist.org/weekly/archives/2021/06/29/4.htm
29 Jun 2021

Take a tiered approach to CVD

Primary care physicians' efforts are paying off as they promote primary prevention of cardiovascular disease, even in a time-pressed visit.
https://acpinternist.org/archives/2022/02/take-a-tiered-approach-to-cvd.htm
1 Feb 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next